Skip to main content
Nick Mulcahy on Muck Rack

Nick Mulcahy

As seen in: WebMD, Medscape, MedicineNet, Genetic Literacy Project, Clinical Neurology News, Internal Medicine News, MDEdge, MDedge Dermatology, MDedge Hematology and Oncology, The Hospitalist
Award-winning senior journalist for Medscape. Previously contributor to HealthDay, MedPageToday. Bylines in WashingtonPost.com, MSNBC, Yahoo, others.

Get in touch with Nick

Contact Nick, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Soon-to-Be Medical Student Awarded $10K After Spotting Melanoma

|
By Nick Mulcahy
| WebMD Verified
Jan. 6, 2022 -- A soon-to-be medical student and former oncology ward volunteer has received a $10,000 scholarship for her education this week after tipping off a Vancouver Canucks staff member about a cancerous mole on the back of his neck during a National Hockey League game in Seattle this past October.
Open in Who Shared View Duplicates (2) Issue with article?

Soon-to-Be Medical Student Awarded $10K After Spotting Melanoma

|
By Nick Mulcahy
| Medscape Verified
A soon-to-be medical student and former oncology ward volunteer has received a $10,000 scholarship for her education this week after tipping off a Vancouver Canucks staff member about a cancerous mole on the back of his neck during a National Hockey League game in Seattle this past October.
Open in Who Shared Issue with article?

The Breast Cancer With No Target May Have One: NOS

|
By Nick Mulcahy
| Medscape Verified
Triple-negative breast cancer (TNBC) — characterized by the lack of expression of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) — remains a challenge to treat because it has no clear biological target. In the hunt for a target, a team of American researchers may have found a druggable spot: the inducible nitric oxide signaling (NOS) pathway.
Open in Who Shared Issue with article?
See all 483 articles